PMID: 3764392Sep 6, 1986Paper

Anthrax meningitis

Schweizerische medizinische Wochenschrift
U N DürstM V Spiegel

Abstract

Anthrax meningitis may complicate cutaneous, inhalation, or gastrointestinal anthrax, although it occurs in less than 5% of patients. Between 1935 and 1985 60 cases of human anthrax were notified in Switzerland. This report of a fatal case in a 54-year-old woman is the third case of inhalation anthrax and the second of meningeal complication with cortical hemorrhages in our country. There was no known source of infection. The clinical, microbiological and histopathological profile, therapy and prognosis are presented.

Related Concepts

Related Feeds

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Related Papers

Acta Médica Portuguesa
Mehmet HarmanTuba Dal
MMWR. Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention (CDC)
Dermatology Online Journal
Cyrus C HsiaKamilia S Rizkalla
© 2021 Meta ULC. All rights reserved